Eleanor is one of the team’s experienced patent litigators, appreciated for her ability to manage complex matters, level-head and sound judgment.
Eleanor is a partner based in London specialising in contentious patent matters with a particular focus and interest in the life sciences and healthcare sectors given her original degree in Cell Biology. Her experience includes co-ordinating and working on multi-jurisdictional patent matters (including patent opposition proceedings at the EPO) and she regularly collaborates with colleagues from our other offices.
Throughout her career, she has acted in high profile proceedings in the field of pharmaceutical patents (including for Baxter Healthcare Corp (Sevoflurane), Warner-Lambert Company (Atorvastatin), Actavis (Pemetrexed and Pregabalin – both Supreme Court cases, Finasteride, Fluvastatin, Entacapone, Pramipexole and Telmisartan), Gedeon Richter (Drospirenone) and Teva (Copaxone)) and also trade mark, design right and copyright (Sir Robert McAlpine Ltd - Alfred McAlpine’s rebranding, Globe GB Limited - designs on the sides of shoes, Mattel - My Scene dolls).
Eleanor's non-contentious practice encompasses advising and supporting clients in a range of sectors in relation to multi-jurisdictional patent portfolio management and strategy (including associated proceedings and commercial agreements), freedom to operate/validity and infringement analysis and intellectual property aspects of corporate transactions including due diligence reports.
Eleanor recently spent over a year seconded to a multinational pharmaceutical company managing a heavy and diverse multi-jurisdictional caseload spanning commercial, regulatory and IP litigation matters and working closely with the different business functions to align legal and commercial strategies. In this role, she developed a deeper understanding of the industry including the pharmaceutical regulatory regime and wider public policy issues at play which are of increasing relevance in patent/SPC litigation. Eleanor’s valuable experience also gave her significant insight as to what is most important in an external advisor and how best to help achieve commercial objectives as pragmatically as possible.
Eleanor is an associate of the Chartered Institute of Patent Attorneys (CIPA) and member of AIPPI (International Association for the Protection of Intellectual Property).